Core Viewpoint - China Resources Medical (01515) expects a decline in profit attributable to shareholders for the year ending December 31, 2025, estimated between RMB 467 million to RMB 516 million, representing a decrease of approximately 17.5% to 8.9% compared to the profit of RMB 566 million for the year ending December 31, 2024 [1] Summary by Relevant Sections - Profit Forecast - The company anticipates a profit attributable to shareholders of approximately RMB 467 million to RMB 516 million for the fiscal year ending December 31, 2025 [1] - This represents a decline of about 17.5% to 8.9% compared to the previous year's profit of RMB 566 million [1] - Adjusted Profit Analysis - Excluding a one-time receipt of approximately RMB 210 million related to the Yan Hua IOT agreement and corresponding corporate income tax, the profit attributable to shareholders is expected to decline by approximately 43.5% to 37.6% compared to the 2024 fiscal year [1] - The decline in profit is less severe than the 57.4% drop observed in the first half of 2025 compared to the same period in 2024, narrowing by approximately 13.9 to 19.8 percentage points [1] - Reasons for Profit Decline - The primary reason for the decrease in profit is attributed to a reduction in average medical insurance expenses leading to decreased operating profits for member medical institutions [1] - Additionally, the scale of the company's IOT (Investment-Operation-Transfer model) business has contracted, further impacting profitability [1]
华润医疗发盈警，预期2025年度股东应占利润约4.67亿元至5.16亿元 同比下降约17.5%至8.9%